Minerva Surgical to Announce Fourth Quarter and Full Year 2022 Financial Results
08 Mars 2023 - 10:01PM
Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company
focused on the treatment of Abnormal Uterine Bleeding (AUB),
announced today that it will release its fourth quarter and full
year 2022 financial results on Tuesday, March 21, 2023. In
conjunction with the release, the company will host a conference
call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m.
Eastern Time to discuss its financial results and recent
highlights.
To access the live call via telephone, please register in
advance using the link here. Upon registering, each participant
will receive an email confirmation with dial-in numbers and a
unique personal PIN that should be used to join the call.
The live webinar of the call may be accessed by visiting the
Recent Events section of the company’s website at
http://ir.minervasurgical.com. A replay of the webinar will be
available on the Company’s website shortly after the conclusion of
the call.
About Minerva Surgical, Inc.
Minerva Surgical is a commercial-stage medical technology
company focused on developing, manufacturing, and commercializing
minimally invasive solutions to meet the distinct uterine
healthcare needs of women. The Company has established a broad
product line of commercially available, minimally invasive
alternatives to hysterectomy, which are designed to address the
most common causes of Abnormal Uterine Bleeding (AUB) in most
uterine anatomies. The Minerva Surgical solutions can be used in a
variety of medical treatment settings and aim to address the
drawbacks associated with alternative treatment methods and to
preserve the uterus by avoiding unnecessary hysterectomies.
INVESTOR RELATIONS CONTACT
Caroline Cornerinvestors@minervasurgical.com 415-202-5678
RELATED LINKS
https://www.aubandme.com
https://www.minervasurgical.com
Minerva Surgical (NASDAQ:UTRS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Minerva Surgical (NASDAQ:UTRS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024